Evidence map›Paper›PMID 33767260›Full record

ArticleScientific reports2021

Studies on the mitochondrial, immunological and inflammatory effects of solvent fractions of Diospyros mespiliformis Hochst in Plasmodium berghei-infected mice.

Oluwole Moses David, John Oludele Olanlokun, Bisola Evelyn Owoniyi, MoyinOluwa Ayeni, Oluwakemi Ebenezer, Neil Anthony Koorbanally

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Synergistic Interaction of Chloroquine withIranian journal of pharmaceutical research : IJPR
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Oluwole Moses DavidDepartment of Microbiology, Ekiti State University, Ado-Ekiti, Nigeria.
John Oludele OlanlokunLaboratories for Biomembrane Research and Biotechnology, Department of Biochemistry, College of Medicine, University of Ibadan, Ibadan, Nigeria. jodel72000@yahoo.com.
Bisola Evelyn OwoniyiDepartment of Microbiology, Ekiti State University, Ado-Ekiti, Nigeria.
MoyinOluwa AyeniDepartment of Microbiology, Ekiti State University, Ado-Ekiti, Nigeria.
Oluwakemi EbenezerSchool of Chemistry and Physics, University of KwaZulu-Natal, Durban, South Africa.
Neil Anthony KoorbanallySchool of Chemistry and Physics, University of KwaZulu-Natal, Durban, South Africa.
Ekiti State University · NGUniversity of KwaZulu-Natal · ZAUniversity of Ibadan · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of medicinal plants in the treatment of malaria is gaining global attention due to their efficacy and cost effectiveness. This study evaluated the bioactivity-guided antiplasmodial efficacy and immunomodulatory effects of solvent fractions of Diospyros mespiliformis in mice infected with a susceptible strain of Plasmodium berghei (NK 65). The crude methanol extract of the stem of D. mespiliformis (DM) was partitioned between n-hexane, dichloromethane, ethyl acetate and methanol. Male Swiss mice (20 ± 2 g) infected with P. berghei were grouped and treated with vehicle (10 mL/kg, control), Artemether lumefantrine (10 mg/kg), 100, 200 and 400 mg/kg of n-hexane, dichloromethane, ethyl acetate and methanol fractions of D. mespiliformis for seven days. Blood was obtained for heme and hemozoin contents while serum was obtained for inflammatory cytokines and immunoglobulins G and M assessments. Liver mitochondria were isolated for mitochondrial permeability transition (mPT), mitochondrial F

Indexed as

DiospyrosAnimalsDrug Evaluation, PreclinicalMalariaMaleMiceMitochondria, LiverParasite LoadPhytotherapyPlant ExtractsPlants, MedicinalPlasmodium bergheiPlant Extracts

Identifiers

PMID33767260
PMCPMC7994402
OpenAlexW3137398037

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.